MEDICAL DEVICE INNOVATION - Medical Device Daily

136
MEDICAL DEVICE INNOVATION 2010
surgical approach with noninvasive laser ablation.”
Kim and Zharov are continuing to explore the optical
properties of this nanoparticle with different dimensions
and to use double- and multi-walled carbon nanotubes as
core and different bioconjugation for targeting normal and
abnormal cells.
“Specifically, we are currently investigating the potential
of golden carbon nanotubes for molecular detection
and eradication of metastasis in the sentinel lymph nodes
and real-time tracking of golden carbon nanotubes in ear
and skin animal vasculatures, as well as an toxicity study of
golden carbon nanotubes in vivo,” he said.
Although the team’s preliminary toxicity results
reveal minimal toxicity, comprehensive toxicity evaluations
are required before any human trials could be initiated.
“We expect the completion of toxicity evaluation in a
few years,” he said.
Their research was supported by the National
Institutes of Health, the National Science Foundation and
the University of Arkansas System’s Division of Agriculture
and the Arkansas Biosciences Institute.
(This story originally appeared in the Sept. 2, 2009 edition
of Medical Device Daily.)
To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547.
Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.